403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
U.S. Tightens Travel Curbs Amid Ebola Outbreak in Africa
(MENAFN) The U.S. Centers for Disease Control and Prevention (CDC) announced Monday a sweeping expansion of travel restrictions and border health measures aimed at blocking a resurgent Ebola strain from reaching American soil, as outbreaks continue to escalate across East and Central Africa.
The CDC, acting in coordination with the Department of Homeland Security and other federal agencies, is rolling out a multi-layered containment strategy targeting the Bundibugyo virus — a strain for which no approved vaccine currently exists and for which treatment remains limited to supportive care.
At the center of the new measures is a travel ban barring non-U.S. passport holders who have been in Uganda, the Democratic Republic of the Congo (DRC), or South Sudan within the past 21 days from entering the country. Authorities will also deploy enhanced public health screening and traveler monitoring at ports of entry, while airlines, international partners, and border officials will be mobilized to identify and manage potentially exposed passengers.
Domestically, the CDC will bolster port health response operations, expand contact tracing, increase laboratory testing capacity, and shore up hospital preparedness nationwide. Additional CDC personnel will be dispatched to support containment efforts in the affected regions.
The case toll as of Monday stands at 11 confirmed and 336 suspected infections in the DRC — including 88 deaths — alongside two confirmed cases and one fatality in Uganda. Reported symptoms mirror classic Ebola presentation: fever, headache, severe weakness, abdominal pain, vomiting, nosebleeds, and vomiting blood.
The CDC characterized the immediate risk to the general U.S. public as low but cautioned that public health measures may be tightened as the situation evolves.
The warning follows a stark assessment issued Sunday by the Africa Centers for Disease Control and Prevention, which flagged a mounting risk of regional spread — heightening alarm among global health authorities tracking the outbreak's trajectory.
The CDC, acting in coordination with the Department of Homeland Security and other federal agencies, is rolling out a multi-layered containment strategy targeting the Bundibugyo virus — a strain for which no approved vaccine currently exists and for which treatment remains limited to supportive care.
At the center of the new measures is a travel ban barring non-U.S. passport holders who have been in Uganda, the Democratic Republic of the Congo (DRC), or South Sudan within the past 21 days from entering the country. Authorities will also deploy enhanced public health screening and traveler monitoring at ports of entry, while airlines, international partners, and border officials will be mobilized to identify and manage potentially exposed passengers.
Domestically, the CDC will bolster port health response operations, expand contact tracing, increase laboratory testing capacity, and shore up hospital preparedness nationwide. Additional CDC personnel will be dispatched to support containment efforts in the affected regions.
The case toll as of Monday stands at 11 confirmed and 336 suspected infections in the DRC — including 88 deaths — alongside two confirmed cases and one fatality in Uganda. Reported symptoms mirror classic Ebola presentation: fever, headache, severe weakness, abdominal pain, vomiting, nosebleeds, and vomiting blood.
The CDC characterized the immediate risk to the general U.S. public as low but cautioned that public health measures may be tightened as the situation evolves.
The warning follows a stark assessment issued Sunday by the Africa Centers for Disease Control and Prevention, which flagged a mounting risk of regional spread — heightening alarm among global health authorities tracking the outbreak's trajectory.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
Comments
No comment